Lenvima (lenvatinib) 10 mg, 30 capsules, India, generic Lenvima (lenvatinib) is used for approved cancer indications including certain thyroid cancers. Medicine delivery from Europe with storage conditions maintained. Payment on delivery. Order at +380996042415 via Viber or WhatsApp.
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
Indications
- for the treatment of patients with progressive locally advanced or metastatic differentiated (papillary, follicular, Hürthle cell) thyroid carcinoma, refractory to radioactive iodine;
- in combination with everolimus for the treatment of patients with advanced renal cell carcinoma after one a previous course of targeted therapy with vascular endothelial growth factor receptor inhibitors.
Dosage regimen
The drug is taken orally, 1 time/day, at approximately the same time, regardless of food intake. The capsule should be swallowed whole with water.
The capsule can also be dissolved in water or apple juice. To do this, pour about 1 tablespoon of water or apple juice into a small glass and place the capsules there without opening or breaking them. Leave the capsules in the liquid for about 10 minutes, then stir for about 3 minutes and drink the liquid. After this, add approximately the same volume of liquid to the glass, rinse the glass with it and drink the contents.
When using lenvatinib in combination with everolimus, they are taken at the same time. It is necessary to read the current instructions for medical use of everolimus.
Treatment with Lenvima® should be carried out under the supervision of a physician with experience in antitumor therapy.
The recommended daily dose of Lenvima® for the treatment of patients with thyroid carcinoma is 24 mg (2 capsules of 10 mg and 1 capsule of 4 mg) 1 time/day.
If the next dose of the drug is missed for more than 12 hours, this dose should be skipped. The next dose of the drug should be taken at the usual time.
The recommended daily dose of Lenvima® for the treatment of patients with renal cell carcinoma is 18 mg (1 capsule of 10 mg and 2 capsules of 4 mg) 1 time / day in combination with 5 mg of everolimus 1 time / day.
